Grass pollen immunotherapy decreases the number of mast cells in the skin.
about
Allergen injection immunotherapy for seasonal allergic rhinitisInduction of tolerance via the sublingual route: mechanisms and applicationsImmunological mechanisms of allergen-specific immunotherapyNature of regulatory T cells in the context of allergic disease.Immune mechanisms of allergen-specific sublingual immunotherapy.SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma.Genetic engineering of pollen allergens for hayfever immunotherapy.Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platform.Sublingual immunotherapy of allergic diseases.Protocol for a double-blind randomised controlled trial of low dose intradermal grass pollen immunotherapy versus a histamine control on symptoms and medication use in adults with seasonal allergic rhinitis (PollenLITE).A review of allergen-specific immunotherapy in human and veterinary medicine.How safe are the biologicals in treating asthma and rhinitis?T-cell responses induced by allergen-specific immunotherapy.What's new in atopic eczema?Adjuvants for allergy vaccinesLipopolysaccharide suppresses IgE-mast cell mediated reactions.Asthma and allergic rhinitis in childhood: what's new.Novel approaches and perspectives in allergen immunotherapy.Immunotherapy for allergic rhinitis.Defining the T cell antigen proteome of wasp venom.Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses.Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium.Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI).Dermatophagoides pteronyssinus immunotherapy changes the T-regulatory cell activity.Histamine reactivity of the skin.Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges.
P2860
Q24243115-2CCB9D04-DE91-4675-AD45-402A4E7261B4Q27022140-A36C42F8-F0DF-44FF-A3A2-610AF6798020Q28265326-FD0C076D-702E-45B2-8103-808346EB0CE1Q33846653-D02E1375-0DB0-440C-9FC3-E93DA94C35F2Q34484071-779EC39B-D447-4082-860B-6031B9AE89C5Q34577305-5349360A-8DEB-462B-BD18-E7B83D3163FEQ35193547-55FC4B84-E144-45AB-8ECE-61EE606243CAQ36056484-E8F2C658-4829-4D38-8632-0449E11FC38CQ36583727-67FF0C0E-034D-474D-8D8B-974DF6933489Q37153212-B5503B0A-7C5D-4236-86DD-0CE8B0D62A3AQ37423369-65EAFF38-9AF1-47C6-9D84-EC485F7B8B1EQ37479670-8350F3E0-2705-4F50-8F76-4531A191D3A1Q37735267-8A23C8E7-7AEA-4A2F-A68C-4E3B451CAD50Q37740142-8C0C1F8E-1C80-4ED6-9580-6ABFA1A40912Q38055323-E089E7D0-ADCA-4ACB-B1EE-5A9B42804278Q38612009-AB0B549C-F258-40DD-8576-29E3234F83EFQ39012986-910F1F9B-F248-4CC0-951F-7DDAA89B7C08Q39103046-3F9F1D96-BE28-46F0-8314-107BE0472C88Q39260807-5EAD8F5A-AAD8-4D66-AD51-DB850E6A25BCQ40282948-08A7A97C-776A-4F15-913E-9C54434167EEQ40511372-8D11093D-7331-46A2-8931-D526D9D2207BQ40593688-4299EAFA-6036-4911-BF86-35E8B1D81990Q40744033-FC5CC984-FE0D-4A05-97AA-271A8DBB61E5Q41697162-665F120D-697B-4932-A9F1-569DEA58395DQ43605733-12E88C6D-4C09-4889-BB98-9DEB53ED8C17Q47602618-E9CBF69B-CC39-4335-BC39-579CD080CEBB
P2860
Grass pollen immunotherapy decreases the number of mast cells in the skin.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Grass pollen immunotherapy decreases the number of mast cells in the skin.
@en
type
label
Grass pollen immunotherapy decreases the number of mast cells in the skin.
@en
prefLabel
Grass pollen immunotherapy decreases the number of mast cells in the skin.
@en
P2093
P2860
P1476
Grass pollen immunotherapy decreases the number of mast cells in the skin
@en
P2093
P2860
P304
P356
10.1046/J.1365-2222.1999.00678.X
P50
P577
1999-11-01T00:00:00Z